Evidence map›Paper›PMID 37941533›Full record

ArticleOsteoporosis and sarcopenia2023

BONEcheck: A digital tool for personalized bone health assessment.

Dinh Tan Nguyen, Thao P Ho-Le, Liem Pham, Vinh P Ho-Van, Tien Dat Hoang, Thach S Tran, Steve Frost, Tuan V Nguyen

Open access · diamondAbstract read
In one paragraph

Article in Osteoporosis and sarcopenia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. AI/ML-based computational models for toxicity prediction.Environmental science and pollution research international · 2026
    Review
  2. Review
  3. Asia-Pacific consensus for the management of osteoporosis in men.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Dinh Tan NguyenSchool of Biomedical Engineering, University of Technology, Sydney, Australia.
Thao P Ho-LeSchool of Biomedical Engineering, University of Technology, Sydney, Australia.
Liem PhamSaigon Precision Medicine Research Center, Ho Chi Minh, Viet Nam.
Vinh P Ho-VanFaculty of Engineering and Information Technology, Hatinh University, Hatinh, Viet Nam.
Tien Dat HoangFaculty of Engineering and Information Technology, Hatinh University, Hatinh, Viet Nam.
Thach S TranSchool of Biomedical Engineering, University of Technology, Sydney, Australia.
Steve FrostUniversity of Wollongong, Wollongong, Australia.
Tuan V NguyenSchool of Biomedical Engineering, University of Technology, Sydney, Australia.
University of Technology Sydney · AUUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Osteoporotic fracture is a significant public health burden associated with increased mortality risk and substantial healthcare costs. Accurate and early identification of high-risk individuals and mitigation of their risks is a core part of the treatment and prevention of fractures. Here we introduce a digital tool called 'BONEcheck' for personalized assessment of bone health. Methods: The development of BONEcheck primarily utilized data from the prospective population-based Dubbo Osteoporosis Epidemiology Study and the Danish Nationwide Registry. BONEcheck has 3 modules: input data, risk estimates, and risk context. Input variables include age, gender, prior fracture, fall incidence, bone mineral density (BMD), comorbidities, and genetic variants associated with BMD. Results: Based on the input variables, BONEcheck estimates the probability of any fragility fracture and hip fracture within 5 years, subsequent fracture risk, skeletal age, and time to reach osteoporosis. The probability of fracture is shown in both numeric and human icon array formats. The risk is also contextualized within the framework of treatment and management options on Australian guidelines, with consideration given to the potential fracture risk reduction and survival benefits. Skeletal age was estimated as the sum of chronological age and years of life lost due to a fracture or exposure to risk factors that elevate mortality risk. Conclusions: BONEcheck is an innovative tool that empowers doctors and patients to engage in well-informed discussions and make decisions based on the patient's risk profile. Public access to BONEcheck is available via https://bonecheck.org and in Apple Store (iOS) and Google Play (Android).

Indexed as

BONEcheckBONEcheck guidelinesOsteoporosis predictionResearch translationRisk assessment toolsRisk prediction

Identifiers

PMID37941533
PMCPMC10627863
OpenAlexW4386865921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.